TIDILAN INJECTION contains Isoxsuprine which belongs to the group of medicines called Vasodilators. It is used in the management of premature labor (when the uterus contraction starts for birth too early than usual) or threatened abortion, cerebral vascular insufficiency (poor blood flow to the brain) and arteriosclerosis obliterans (hardening of the arteries).
TIDILAN INJECTION is also used to manage Buerger's disease (blood vessels become inflamed, swell and can become blocked with blood clots) and Raynaud’s phenomenon (decreased blood flow to the nose, ears, fingers, toes, nipples or knees). You should avoid participating in any stressful or heavy activities in order to manage premature labor.
Avoid smoking tobacco during TIDILAN INJECTION management as it can further constrict your blood vessels. TIDILAN INJECTION should not be used immediately postpartum (after delivering a baby) or if you have a bleeding disorder, heart disease, severe anemia, premature detachment of the placenta and premature labor if there is infection.
TIDILAN INJECTION should be used in pregnant women only if the potential benefits outweigh the potential risks to mother and her baby. There are no reports of problems with TIDILAN INJECTION use in breastfeeding babies but consult your doctor before receiving it.
TIDILAN INJECTION is not recommended for use in children. The most common side effects of receiving TIDILAN INJECTION are fast heartbeat and vomiting. Contact your physician if any of the symptoms deteriorate.
No content available
